Home /
It goes without saying that 2020 has been a strange year for us all. Whilst there have been many challenges to overcome, we are proud of the way we have adapted and turned 2020 into a successful year. In our annual year in review blog, we share our highlights and...
OracleBio's Chief Operations Officer, Dr John Waller, recently joined Roland Linder on Scottish Development International's What in the Life Sciences podcast. During the podcast, Roland and John have a conversation about the field of Quantitative Digital Pathology....
‘Welcome to Fight Club. The first rule of Fight Club is: you do not talk about Fight Club.’ (Chuck Palauniak 1996). Fight Club and Histopathology may not overlap widely, but their intersection is not empty. Dr Wilfred Weinstein of Los Angeles spoke of ‘The Silence...
The Challenge To meet increasing demand from Clients, OracleBio recently expanded its image analysis software capabilities to include increased licenses for the Visiopharm platform including AI capabilities, as well as an integration of Indica Labs’ AI module to its...
Image Quality Control (QC) is an essential first step in any image analysis study. At OracleBio, we QC check every image before analysis and only proceed with images that meet certain criteria, taking into consideration 1) Image Scan 2) Tissue Section and 3) Staining....
Getting the image quality right before embarking on advanced image analysis may be an obvious statement to make. However, there are multiple ways to assess image quality and this speaks to the need for robust quality control (QC) processes throughout an image...
Good quality image analysis requires good quality images. Therefore, before beginning quantitative analysis it is essential to first conduct a Quality Control (QC) review of all images to assess suitability for analysis and to only proceed with images that meet...
2019 was a big year for OracleBio in many aspects, with new software, new team members and new clients. In our annual year in review blog, we share our key highlights and insights into our activity from the past year. Deep Learning As expected, artificial intelligence...
According to the American Cancer Society, an estimated 88,000 new cases of gynecologic cancer are diagnosed per year in the U.S., and over 29,000 American women will lose their battle with this deadly disease. Over the past 12 months, OracleBio has supported work lead...
Selecting the right therapeutic disease indication in which to trial new therapies is a notoriously difficult task. Failure to choose the right indication can result in failure in Phase II/III trials resulting in drug discovery programs being halted which, given...
The production of robust tissue-based quantitative histopathology data is completely dependent on high quality sample preparation and staining. Failure to ensure that samples are of a high quality can hinder subsequent image analysis processes, negatively impact on...
The characterisation of immune cells within the tumor microenvironment and their potential impact on cancer treatment and prognosis has been the subject of intense investigation over recent years. Non-small cell lung cancer (NSCLC) patients have impaired immune...